Diabetes Care 2001;275-79 65th Scientific Sessions of the American Diabetes Association. of a combination of weight loss therapies for type 2 diabetes. …
Metabolic Syndrome Bibliography
Bethlehem, Palestine
1 Endocrinology and Metabolism Clinics of North America Metabolic
Syndrome: Parts I and II June 2004 and September 2004
2 Hurst, RT, Lee, RW Increased Incidence of Coronary Atheroscloerosis in
Type 2 Diabetes Mellitus: Mechanisms and Management Ann Intern Med
2003;139:824-834
3 Colhoun, JM, Betteridge, DJ, et al Primary Prevention of
Cardiovascular disease with Atorvastatin in Type 2 diabetes in the
Collaborative Atorvastatin Diabetes Study CARDS: Multicentre Randomized
Placebo-controlled Trial Lancet 2004;365-96
4 Weiss, R, Dziura, J, et al Obesity and the Metabolic Syndrome in
Children and Adolescents NEJM 2004;350:2362-74
5 Abdul-Rahim, HF, Husseine, A, et al The Metabolic Syndrome in the
West Bank Population, An urban-rural comparison Diabetes Care 2001;275-79
6 Barclay, L, Nghiem, HT, Tobacco Smoke May Put Adolescents at Risk for
Metabolic Syndrome Circulation 2005
7 Vinik, AI, Natural History of the Metabolic Syndrome and Type 2
diabetes: The Ticking Clock 65th Scientific Sessions of the American
Diabetes Association
8 Milionis, HJ, et al
Metabolic Syndrome Increases Stroke Risk in the
Elderly Stroke 2005;36:1372-1376
9 Segal, P, Zimmet, PZ, 1st International Congress on Prediabetes and
the Metabolic Syndrome, April 13-16, 2005; Berlin, Germany Medscape
Diabetes Endocrinology, 2005;72
10 Staels, B, Fruchart, JC, Therapeutic Roles of Peroxisome Proliferator-
Activated Receptor Agonists Diabetes 2005;548:2460-2470
11 Makhsida, N, Shah, J, et al Hypogonadism and Metabolic Syndromne:
Implications for Testosterone Therapy J Urol 2005 Sept;1743:827-34
12 Peters, Anne, The Broadening Domain of the Metabolic Syndrdome 65th
Scientific Session of the American Diabetes Association
13 Kahn, R, Buse, J, et al The Metabolic Syndrome: Time for a Critical
Appraisal Diabetes Care 2005;28:2289-2304
14 Shulman, A, Mangelsdorf, D, Retinoid X Receptor Heterodimers in the
Metabolic Syndrome NEJM 2005; 353:604 -15
15 Program and Abstracts of the 65th Scientific Sessions of the American
Diabetes Association; June 10-14, 2005; San Diego, California
16 Redmon, JB, Raatz, SK, et al Two-year outcome of a combination of
weight loss therapies for subjects with type 2 diabetes: a randomized
trial Diabetes Care
2005;28:1311-1315
17 Domanski,M, Mitchell, G, et al Pulse pressure and cardiovascular
disease-related mortality: follow-up study of the Multiple Risk Factor
Intervention Trial MRFIT JAMA 2002 May 22-29;28720:2666-2830
18Sytkowski, PA, Dagostino, RB, et al Secular trends in long-term
sustained hypertension, long-term treatment and cardiovascular mortality
The Framingham Heart Study 1950-1990 Circulation 1996 Feb15;934:697-
703
19 Redmon, JB, Reck, KP, et al Two-year outcome of a combination of
weight loss therapies for type 2 diabetes Diabetes Care 2005;28:1311-1315
20 Eurich, DT, Majumdar, SR, et al Improved clinical outcomes
associated with metformin in patients with diabetes and heart failure
Diabetes Care 2005;28:2345-2351
21 Gillespie, EL, White, CM, et al The impact of ACE inhibitors or
Angiotensin II receptor blockers on the development of new-onset type 2
diabetes Diabetes Care 2005; 28:2261-2266
22 American Diabetes Association: Clinical Practice Recommendations 2005
Diabetes Care, January 2005;28:Supplement 1
